Sofos Investments, Inc.
- SEC CIK
- 0001741736
- Latest filing
- May 8, 2026
NEO holding history
Neogenomics Inc in every 13F filed by Sofos Investments, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NEO overviewAll 13F holders of NEOFull Q1 2026 holdings
- Shares (Q1 2026)
- 4
- Value
- $30
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 4 | $30 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 4 | $47 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 4 | $31 | <0.1% | – | No prior filing | Holders |
| Q2 2025 | – | – | – | – | Not filed | Holders |
| Q1 2025 | 4 | $38 | <0.1% | – | No prior filing | Holders |
| Q3 2024 | – | – | – | – | Not filed | Holders |
| Q2 2024 | 4 | $55 | <0.1% | −6−60.0% | Reduced | Holders |
| Q1 2024 | 10 | $160 | <0.1% | −3−23.1% | Reduced | Holders |
| Q4 2023 | 13 | $205 | <0.1% | −108−89.3% | Reduced | Holders |
| Q3 2023 | 121 | – | – | +115+1,916.7% | Added | Holders |
| Q2 2023 | 6 | $0 | 0.0% | −17−73.9% | Reduced | Holders |
| Q1 2023 | 23 | $116 | <0.1% | +14+155.6% | Added | Holders |
| Q4 2022 | 9 | $20 | <0.1% | −18−66.7% | Reduced | Holders |
| Q3 2022 | 27 | – | – | −3−10.0% | Reduced | Holders |
| Q2 2022 | 30 | – | – | −6−16.7% | Reduced | Holders |
| Q1 2022 | 36 | – | – | −66−64.7% | Reduced | Holders |
| Q4 2021 | 102 | – | – | +95+1,357.1% | Added | Holders |
| Q3 2021 | 7 | – | – | 00.0% | Unchanged | Holders |
| Q2 2021 | 7 | $45.0K | <0.1% | +7 | New | Holders |